Newsletters

 

The Regulation Digest

 

A weekly compendium of regulatory policy, news, and analysis.

 

SUBSCRIBE TODAY!

This week's edition...

 

 

May 26, 2021 -- Volume 10, Number 20

Features rulemaking activity related to COVID-19 by CBP and NRC. Plus other notable actions by the FDIC, DHS, NTSB, NIH, and DOT.

With opinions and analysis from Daniel Pérez, Bridget Dooling, John Graham, Binyamin Appelbaum, Liya Palagashvili, Ilya Shapiro, John Tamny, Jennifer Schulp, Timiebi Aganaba, Christopher Walker, Jennifer Huddleston, Michael Cannon, Matthew Mitchell, and Jonathan Masur.

Plus news from Washington Post, The Hill, New York Times, Wall Street Journal, Reuters, Institutional Investor, Associated Press, and Bloomberg.

Photo of Roslyn Layton

Dr. Roslyn Layton

Visiting Scholar
American Enterprise Institute

"The Regulation Digest is better than an algorithm."

Photo of Adam White.

Adam J. White

Executive Director
Center for the Study of the Administrative State

"I recommend everyone subscribe to the Regulation Digest. It's really indispensable."

Previous editions

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by Treaury, DHS, CMS, and ED. Plus other notable actions by EPA, CPSC, DOL, and DHS.

With opinions and analysis from Laura Stanley, Phil Gramm, Patrick McLaughlin, Mark Calabria, Roslyn Layton, Robert Graboyes, Barak Orbach, Ilya Shapiro, Wayne Crews, Arthur Fraas, Hannah Downey, James Capretta, and Howard Husock.

Plus news from Washington Post, The Hill, New York Times, Wall Street Journal, Associated Press, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS, EOP, FDA, AID, and FNS. Plus other notable actions by DHS, DOL, NHTSA, and FWS.

With opinions and analysis from Susan Dudley, Bruce Yandle, David Leonhardt, Laurence Tribe, Maryam Nasir, Richard Revesz, Monique King-Viehland, Daniel Lyons, Diego Zuluaga, Randy May, Michael Hendrix, Ana Babus, and Shoshana Weissmann.

Plus news from Reuters, The Hill, New York Times, Wall Street Journal, Associated Press, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by ED and CMS. Plus other notable actions by DOL, EPA, DOT, DHS, OMB, FDA, and DEA.

With opinions and analysis from Veronique de Rugy, Courtney Joslin, Cass Sunstein, Jennifer Schulp, Fernando Hernandez-Lepe, Martha Fedorowicz, Jonathan Adler, Adam Thierer, Eli Lehrer, Robert Graboyes, David Michaels, Richard Pierce, Tala Al Jabri, Dan Farber, Wayne Crews, Matthew Mitchell, and Don Boudreaux.

Plus news from Roll Call, The Hill, New York Times, Reuters, Wall Street Journal, Associated Press, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CFPB, ED, FDA, HRSA, and CBP. Plus other notable actions by DHS, EPA, Commerce, FERC, and DOE.

With opinions and analysis from Bridget Dooling, Laura Stanley, Zhoudan Xie, Howard Beales, Josiah Neeley, Joseph Aldy, Matthew Adler, Sandeep Jauhar, Nicole Cimbura, Gilbert Metcalf, Lawrence Goulder, Christopher Walker, Robert Atkinson, Samantha Gross, Kent Lassman, and Sarah Ladin.

Plus news from The Hill, New York Times, Wall Street Journal, Bloomberg, Politico, Washington Post, Government Executive, Treatment Magazine, and Associated Press.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS, FNS, PTO, FDA, and NCUA. Plus other notable actions by DOI, SSA, DHS, USCIS, HHS, and CFPB.

With opinions and analysis from Mark Febrizio, Scott Gottlieb, Tyler Cowen, Christina Parajon Skinner, Jeffrey Singer, Danielle Butcher, Holman Jenkins, Liza Reed, Cass Sunstein, Scott Wallsten, Shane Tews, Darya Minovi, Randy May, Adam Thierer, and Liya Palagashvili.

Plus news from Axios, The Hill, New York Times, Reuters, Wall Street Journal, Associated Press, Bloomberg, and E&E News.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CFPB, ED, FCC, CDC, and CLA. Plus other notable actions by CFTC, CPSC, and DOE.

With opinions and analysis from Steven Balla, Bridget Dooling, Daniel Pérez, Edward Glaeser, Cary Coglianese, Kofi Ampaabeng, Elizabeth Nolan Brown, Robert Graboyes, Roslyn Layton, Beth Garza, Ilya Somin, James Broughel, Arther Fraas, Randall Lutter, Heather Reams, Jennifer Huddleston, Judge Glock, and Ellen Wald.

Plus news from Los Angeles Times, The Hill, New York Times, Reuters, Wall Street Journal, Bloomberg, and E&E News.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by FDA, HUD, and CLA. Plus other notable actions by DOT, CPSC, HUD, EPA, and ETA.

With opinions and analysis from Daniel Pérez, Christopher Carrigan, Stuart Shapiro, Utsha Khatri, Elizabeth Samuels, Richard Schmalensee, David Schoenbrod, Eugene Volokh, James Capretta, Greg Ip, Ilya Somin, Dan Farber, Tom Wheeler, and Ashley Johnson.

Plus news from Government Executive, The Hill, New York Times, Regulatory Focus, Wall Street Journal, Bloomberg, and E&E News.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by the CDC and NOAA. Plus other notable actions by DOE, DOL, and EPA.

With opinions and analysis from Sally Katzen, Leah Brooks, Jonathan Adler, Randy May, Ilya Somin, Caleb Watney, Liya Palagashvili, Andy Kessler, Dan Farber, Osub Ahmed, and Tom Wheeler.

Plus news from NPR, The Hill, New York Times, Associated Press, Wall Street Journal, Bloomberg, Washington Post, and Daily Beast.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by FCC, DHS, CBP, SBA, and HUD. Plus other notable actions by EPA, HHS< DHS, FCC, DOE, and CFPB.

With opinions and analysis from Susan Dudley, Steven Balla, Bridget Dooling, Daniel Pérez, Brandon Dorfman, Greg Ip, Scott Gottlieb, James Capretta, Jonathan Adler, Susan Tierney, Rachel Sachs, Daniel Walters, and Dan Bosch.

Plus news from The Hill, New York Times, Associated Press, Wall Street Journal, Bloomberg, Washington Post, The Verge, Reuters, and NBC.

 

 

 

The Regulatory Studies Center Update

 

A monthly(ish) collection of working papers, events, op-eds, and insights.

 

SUBSCRIBE TODAY!

Most recent edition...

 

 

May 2021

This update features our recent report by Bridget Dooling and Laura Stanley Unsupervised Use of Opioid Treatment Medications, which is the second part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes a Congressional testimony by Howard Beales, and analysis of the Congressional Review Act by Daniel Pérez, President Biden's actions to undo Trump administration rulemaking by Mark Febrizio, and a report to the Administrative Conferece of the United States by Steve Balla and Bridget Dooling.

Also featured is Bridget Dooling's appearance on the GovActually podcast with Princeton University professor Martha Coven to discuss being a part of the Biden Transition Team.

Plus various op-eds in the The Philadelphia Inquirer and Forbes, events with ABA AdLaw Section, Society for Benefit-Cost Analysis, Environmental Law Institute, Midwest Political Science Assocation, and the GW Economics Department, and quotes in popular media outlets, including The Wall Street Journal, NPR, Government Executive, Daily Beast, Marketplace, and Axios.

Previous editions

FULL NEWSLETTER

This update features our recent report by Bridget Dooling and Laura Stanley Telemedicine & Initiating Buprenorphine Treatment, which is part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes scholarly articles by Susan Dudley on President Biden's early executive actions, Jerry Ellig on surface freight deregulation, and Bridget Dooling on GAO's role in the administrative state and her innovative research on bespoke regulatory review.

There is also an analysis of regulatory sentiment by Zhoudan Xie, a reflection on the year that was 2020 by Mark Febrizioi and Zhoudan Xie, opioid treatment waivers by Laura Stanley, and advice for the Biden-Harris administration from Richard J. Pierce, Jr. and Susan Dudley.

Plus various op-eds in the Wall Street Journal, The Hill, Forbes, and Government Executive, events with American Economic Association, Federalist Society, and Southern Economic Association, and quotes in popular media outlets, including the Wall Street Journal, Federal News Network, Science, Bloomberg, USA Today, and Axios.

FULL NEWSLETTER

This update features our recent Delivering the Goods event with analysis from STB general counsel Craig Keats and UW-Milwaukee professor James Peoples, and includes scholarly articles by Bridget Dooling on the Administrative Procedure Act, Brian Mannix on the EPA's 50th anniversary, and Aryamala Prasad & Daniel Pérez on the effects of GDPR.

There is also an analysis of FCC spectrum auctions by Gerald Brock, and public interest comments related to immigration policies from DHS by Mark Febrizio, OPM's paid parental leave by Joseph Cordes & Jerry Ellig, and a Section 230 petition by Jerry Ellig.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Wall Street Journal, New York Times, The Hill, Bloomberg, Forbes, Politico, Reuters, Audubon Magazine, Government Executive, and Law360.

FULL NEWSLETTER

This update includes scholarly articles by Susan Dudley on the durability of OIRA's regulatory oversight, Bridget Dooling on a new concept for independent agency rulemaking called Bespoke Regulatory Review, Jerry Ellig on how to improve economic analysis at federal agencies, and Zhoudan Xie's review of regulations and news coverage during the COVID-19 pandemic.

There are also public interest comments on a recent EPA proposal by Brian Mannix and Joe Cordes, a review of the Spring Unified Agenda by Daniel Pérez, and Mark Febrizio provides a full analysis of the Trump Administration's regulatory budget.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the New York Times, The Hill, Bloomberg, Forbes, Politifact, and Vox.

FULL NEWSLETTER

This update includes public interest comments to the DEA, DOT, FDA, and USDA from Laura Stanley, John Bertino, and Mark Febrizio.

Academic papers by Susan Dudley, Zhoudan Xie, and Steven Balla, plus articles published by the Brookings Institution and The Regulatory Review. And a four-chapter report based on a co-operative agreement with the USDA.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Washington Post, The Hill, Bloomberg, Forbes, and CQ Roll Call.

FULL NEWSLETTER

This update includes testimony before the House Financial Services Subcommittee on Oversight and Investigations, and the General Services Administration by Steven Balla.

Academic papers by Bridget Dooling, Jerry Ellig, Chris Carrigan, Mark Febrizio, and Susan Dudley, and public interest comments submitted to the Surface Transportation Board, Council on Environmental Quality, the Office of Management and Budget, and the Federal Deposit Insurance Corporation.

Plus various commentaries, op-eds, and quotes in popular media outlets, including Federal News Network, The Hill, E&E News, Forbes, and Government Executive.